Small cell lung cancerStagingSurgeryResectionFor more than 50 years, small cell lung cancer (SCLC) has been staged mainly as either limited or extensive stage disease. Small published series of resected SCLC have suggested that the tumor, node, metastases (TNM) pathologic staging correlates with ...
Table 1. TNM Classification for Non-Small Cell Lung Cancer (Open Table in a new window) Primary tumor (T) TX Primary tumor cannot be assessed, or tumor is proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging or bronchoscopy T0 No evidence...
Afatinib, an irreversible ErbB-family blocker, could improve the survival of advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer patients (NSCLCm+). This phase II trial (NCT04201756) aimed to assess the feasibility of neoad
Lung cancer staging I 58 (41.7%) II 35 (25.2%) III 39 (28.1%) IV 7 (5.0%) Pathological type SCC 81 (58.3%) Adenocarcinoma 40 (28.8%) Large cell carcinoma 4 (2.9%) NSCLC NOS/mixed 12 (8.6%) NSCLC others 2 (1.4%) Grade G1 16 (11.5%) G2 57 (41.0%) G3 47 (33.8%...
bTMB, blood-based tumor mutational burden; MSAF, maximum somatic allele frequency; NSCLC, non-small cell lung cancer; QC, quality control. a Staging based on International Association for the Study of Lung Cancer Lung Cancer Staging Project 8th Edition of the TNM Classification for Lung Cancer28...
Non–small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. Histologically, NSCLC is divided into adenocarcinoma, squamous cell carcinoma (SCC) (see the image below), and large cell carcinoma. [1] Patients with NSCLC require a complete staging workup to evaluate the...
Objective To study the factors affecting post operative staging and survival in non small cell lung cancer (NSCLC) patients based on the revised TNM staging system adopted by the UICC in 1997. Methods Data were collected from 1757 consecutively operated NSCLC patients, including those receiving compl...
To assess the impact of cell type, age, and gender in addition to pathologic tumor, node, metastasis (TNM) stage in surgically managed stage I-IIIA non-small cell lung cancer (NSCLC) cases from the international staging database of the International Association for the Study of Lung Cancer....
Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification. J Thorac Cardio- vasc Surg. 2000;119:1141-6.Results of surgical treatment of non–small cell lung cancer: validation of the new postoperative pathologic tnm classification....
Is T factor of the TNM staging system a predominant prognostic factor in patho- logic stage I non-small cell lung cancer? J Thorac Cardiovasc Surg 1993;106:90- 4.Ichinose Y, Hara N, Ohta M, Yano T, Maeda K, Asoh H, Katsuda Y (1993) Is T factor of the TNM staging system a ...